KORU Medical Systems entered into Amendment No. 1 to its Amended and Restated Manufacturing and Supply Agreement with Command Medical Products on June 24, 2026. The amendment extends the initial term to December 31, 2031, updates pricing and payment terms, and requires Command to qualify a second manufacturing site by December 31, 2027, with a related termination right for KORU if unmet. It also introduces limited product exclusivity for Command, clarifies IP ownership and licenses, broadens wind-up provisions, makes assignment rights mutual, and removes the non-compete clause. The company expects the changes to strengthen supply resilience and cost management.
Agreement details:
- Agreement type: Amendment to manufacturing and supply agreement
- Counterparty: Command Medical Products
- Signed / Effective: Jun 24 2026 / same
- Duration / Termination: Through Dec 31 2031, auto-renewal for 1-year periods
- Reason: Extend term, update pricing, add second site and selective exclusivity
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.